BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36735254)

  • 1. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
    Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
    JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.
    Pinder MC; Duan Z; Goodwin JS; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2007 Sep; 25(25):3808-15. PubMed ID: 17664460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
    Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
    Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group.
    Lee J; Hur H; Lee JW; Youn HJ; Han K; Kim NW; Jung SY; Kim Z; Kim KS; Lee MH; Han SH; Jung SH; Chung IY
    Cancer; 2020 Jan; 126(1):181-188. PubMed ID: 31454422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.
    Kenzik KM; Mehta A; Richman JS; Kilgore M; Bhatia S
    Cancer; 2018 Nov; 124(21):4221-4230. PubMed ID: 30303522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
    Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH;
    J Natl Cancer Inst; 2012 Sep; 104(17):1293-305. PubMed ID: 22949432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database.
    Choi JY; Cho EY; Choi YJ; Lee JH; Jung SP; Cho KR; Kim CY; Kim YH; Park KH
    Breast Cancer Res Treat; 2018 Aug; 171(1):181-188. PubMed ID: 29737474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study.
    Veiga LH; Curtis RE; Morton LM; Withrow DR; Howell RM; Smith SA; Weathers RE; Oeffinger KC; Moskowitz CS; Henderson TO; Arnold MA; Gibson TM; Leisenring WM; Neglia JP; Turcotte LM; Whitton JA; Robison LL; Armstrong GT; Inskip PD; Berrington de Gonzalez A
    JAMA Pediatr; 2019 Dec; 173(12):1171-1179. PubMed ID: 31657853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
    Baech J; Hansen SM; Lund PE; Soegaard P; Brown PN; Haaber J; Jørgensen J; Starklint J; Josefsson P; Poulsen CB; Juul MB; Torp-Pedersen C; El-Galaly TC
    Br J Haematol; 2018 Dec; 183(5):717-726. PubMed ID: 30406945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.
    Blanco JG; Leisenring WM; Gonzalez-Covarrubias VM; Kawashima TI; Davies SM; Relling MV; Robison LL; Sklar CA; Stovall M; Bhatia S
    Cancer; 2008 Jun; 112(12):2789-95. PubMed ID: 18457324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
    Jacobse JN; Schaapveld M; Boekel NB; Hooning MJ; Jager A; Baaijens MHA; Hauptmann M; Russell NS; Rutgers EJT; Aleman BMP; Sonke GS; van Leeuwen FE
    Breast Cancer Res Treat; 2021 Jan; 185(1):205-214. PubMed ID: 32964358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.
    Kremer LC; van Dalen EC; Offringa M; Ottenkamp J; Voûte PA
    J Clin Oncol; 2001 Jan; 19(1):191-6. PubMed ID: 11134212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
    Boddicker NJ; Larson MC; Castellino A; Herrmann J; Inwards DJ; Thanarajasingam G; Maurer MJ; Allmer C; Witzig TE; Nowakowski GS; Habermann TM; Villarraga HR; Slager SL; Cerhan JR; Thompson CA
    Am J Hematol; 2021 Aug; 96(8):979-988. PubMed ID: 33971040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.
    van Dalen EC; van der Pal HJ; Kok WE; Caron HN; Kremer LC
    Eur J Cancer; 2006 Dec; 42(18):3191-8. PubMed ID: 16987655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.
    Du XL; Xia R; Liu CC; Cormier JN; Xing Y; Hardy D; Chan W; Burau K
    Cancer; 2009 Nov; 115(22):5296-308. PubMed ID: 19672997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab-related cardiotoxicity among older patients with breast cancer.
    Chavez-MacGregor M; Zhang N; Buchholz TA; Zhang Y; Niu J; Elting L; Smith BD; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2013 Nov; 31(33):4222-8. PubMed ID: 24127446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
    Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
    JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study.
    Thavendiranathan P; Abdel-Qadir H; Fischer HD; Camacho X; Amir E; Austin PC; Lee DS
    J Clin Oncol; 2016 Jul; 34(19):2239-46. PubMed ID: 27091709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Frailty Index at 66 Years of Age and Association With Age-Related Diseases, Disability, and Death Over 10 Years in Korea.
    Jang J; Jung H; Shin J; Kim DH
    JAMA Netw Open; 2023 Mar; 6(3):e2248995. PubMed ID: 36862415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.